SynthesisJournal of the Chinese Medical Association : JCMA2023
Robot-assisted versus open hepatectomy for liver tumors: Systematic review and meta-analysis.
Synthesis in Journal of the Chinese Medical Association : JCMA, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Clinical effectiveness of robotic versus laparoscopic and open surgery: an overview of systematic reviews.BMJ open · 2024Pooled it
- Comparison of robotic and open liver resections for primary liver tumors: a multicenter retrospective analysis of perioperative outcomes, morbidity and mortality.Surgical endoscopy · 2026Article
- Robotic Gastrointestinal Surgery Compared to Conventional Approaches: An Umbrella Review of Clinical and Economic Outcomes.Journal of clinical medicine · 2025Review
- Robotic versus laparoscopic hepatectomy for liver malignancies (ROC'N'ROLL): a single-centre, randomised, controlled, single-blinded clinical trial.The Lancet regional health. Europe · 2024Article
- Minimally invasive approach is preferred for clinical stage 1 endometrioid-type endometrial cancer.Journal of the Chinese Medical Association : JCMA · 2024Article
- Winners of the 2022 honor awards for excellence at the annual meeting of the Chinese Medical Association-Taipei: Part III.Journal of the Chinese Medical Association : JCMA · 2023Article
- The 2022 Journal of Chinese Medical Association Award-Winning Research illuminates the promise of integrating acupuncture and related techniques in rheumatoid arthritis treatment.Journal of the Chinese Medical Association : JCMA · 2023Article
- Early oral diet may enhance recovery from benign gynecologic surgery: A single center prospective study.Journal of the Chinese Medical Association : JCMA · 2023Article
- Winners of the 2022 honor awards for excellence at the annual meeting of the Chinese Medical Association-Taipei: Part I.Journal of the Chinese Medical Association : JCMA · 2023Article
- Pelvic organ prolapse: Minimally invasive approach.Journal of the Chinese Medical Association : JCMA · 2023Article
- Minimally invasive surgery for hepatocellular carcinoma.Journal of the Chinese Medical Association : JCMA · 2023Article
Corrections and comments
- Commented on by
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis meta-analysis was conducted to evaluate the effectiveness and safety of robot-assisted hepatectomy (RAH) versus open hepatectomy (OH) for liver tumors (LT).
methodsA computer-based literature search was conducted to identify all randomized or nonrandomized controlled trials of RAH and OH in the treatment of LT from January 2000 to July 2022. Study-specific effect sizes and their 95% confidence intervals (CIs) were combined to calculate the pooled values, using a fixed-effects or random-effects model.
resultsEight studies were included, with a combined total of 1079 patients. Compared with the OH group, the RAH group was found to involve less blood loss (standardized mean difference [SMD] = -152.52 mL; 95% confidence interval [CI] = -266.85 to 38.18; p = 0.009), shorter hospital stay (SMD = -2.79; 95% CI = -4.19 to -1.40; p < 0.001), a lower rate of postoperative complications (odds ratio [OR] =0.67; 95% CI = 0.47-0.95; p = 0.02), and a lower recurrence rate (OR = 0.42; 95% CI = 0.23-0.77; p = 0.005). However, operative time was longer in the RAH group than in the OH group (SMD = 70.55; 95% CI = 37.58-103.53; p < 0.001).
conclusionThis systematic review shows that RAH is safe and feasible in the treatment of LT.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.